Trade PYXS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Pyxis Oncology, Inc. (PYXS) is trading at US$1.61, down 3.01% today as of Nov 5, 16:00 EST. The company has a market capitalisation of US$256.9M. Over the past 52 weeks, PYXS has traded between US$1.03 and US$5.55. On Syfe you can trade PYXS with $0 commission and add it to your watchlist.
| Previous close | US$1.66 |
|---|---|
| Market cap | US$256.9M |
| 52-week range | US$1.03 – US$5.55 |
| Volume | 1.15M |
| Exchange | US |
Pyxis Oncology, Inc.
Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The firm focuses on the development of product candidates to directly kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. The company was founded by David Steinberg, Shaan C. Gandhi, and John L. Flavin on June 11, 2018 and is headquartered in Boston, MA.
Year: 2021
Update: Pyxis Oncology Shares Fall After Pricing Public Offering of Common Stock, Warrants
Sep 30, 6:46 PM · MT Newswires
Pyxis Oncology Prices Public Offering of Common Stock, Warrants
Sep 30, 7:58 AM · MT Newswires
Wedbush Lifts Price Target on Pyxis Oncology to $8 From $6, Keeps Outperform Rating
Sep 9, 2:13 PM · MT Newswires
Pyxis Oncology Reports 36% Response Rate in Phase 1 MICVO Study
Sep 9, 12:26 PM · MT Newswires
Pyxis Oncology, Inc. (PYXS) stock is trading at US$1.61, -3.01% from the previous close of US$1.66.
The market cap for Pyxis Oncology, Inc. (PYXS) stock is approximately US$256.9M.
The 52-week high for Pyxis Oncology, Inc. (PYXS) stock is US$5.55.
The 52-week low for Pyxis Oncology, Inc. (PYXS) stock is US$1.03.
Pyxis Oncology, Inc. (PYXS) does not currently pay a dividend.
Stay on top of PYXS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore